Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 35824 | 91 | 23.9 | 39% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
| 1171 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM | 9352 |
| 35824 | 1 | INO 2628 CZ//EFFICIENCY OF ENTEROHEPATIC CIRCULATION//MNP001 | 91 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | INO 2628 CZ | authKW | 1342226 | 4% | 100% | 4 |
| 2 | EFFICIENCY OF ENTEROHEPATIC CIRCULATION | authKW | 671113 | 2% | 100% | 2 |
| 3 | MNP001 | authKW | 671113 | 2% | 100% | 2 |
| 4 | N N DICYCLOPROPYL METHYL PIPERAZINE DICHLORHYDRATE PHARMACOKINETICS | authKW | 671113 | 2% | 100% | 2 |
| 5 | TRANSITION AND ELIMINATION PROBABILITIES | authKW | 671113 | 2% | 100% | 2 |
| 6 | 2 COMPARTMENT TIME DELAY MODEL | authKW | 335557 | 1% | 100% | 1 |
| 7 | 5 MEHTYL 7 PROPYL 8 2 1H TETRAZOL 5 YLBIPHENYL 4 YLMETHY 1 2 4 TRIAZOLO1 5 CPYRIMIDIN 23H ONE | authKW | 335557 | 1% | 100% | 1 |
| 8 | ADMET ABSORPTION DISPOSITION EXCRETION AND TOXICITY | authKW | 335557 | 1% | 100% | 1 |
| 9 | ADOMINIAN POLYNOMIALS | authKW | 335557 | 1% | 100% | 1 |
| 10 | ANIMAL TO HUMAN SCALING | authKW | 335557 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1418 | 71% | 0% | 65 |
| 2 | Chemistry, Medicinal | 304 | 18% | 0% | 16 |
| 3 | Chemistry, Multidisciplinary | 86 | 22% | 0% | 20 |
| 4 | Mathematical & Computational Biology | 46 | 4% | 0% | 4 |
| 5 | Toxicology | 23 | 5% | 0% | 5 |
| 6 | Biology | 16 | 4% | 0% | 4 |
| 7 | Oncology | 15 | 9% | 0% | 8 |
| 8 | Engineering, Biomedical | 11 | 3% | 0% | 3 |
| 9 | Computer Science, Cybernetics | 11 | 1% | 0% | 1 |
| 10 | Ergonomics | 11 | 1% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | FOR ENTWICKLUNG BIOPHARM | 335557 | 1% | 100% | 1 |
| 2 | IST RICOVERO CURA CARATTERE SCI A NUCL MED | 335557 | 1% | 100% | 1 |
| 3 | IST RICOVERO CURA CARATTERE SCI A PATHOL | 335557 | 1% | 100% | 1 |
| 4 | REGISTRAT DEV DEV KUNDL | 335557 | 1% | 100% | 1 |
| 5 | UNITE FORMAT RECH UFR MATH | 167777 | 1% | 50% | 1 |
| 6 | CHIM THER EUT 1 RUE VAUBENARD | 83888 | 1% | 25% | 1 |
| 7 | CHIM MINERALE STRUCT | 55924 | 1% | 17% | 1 |
| 8 | S CAROLINA PHARM | 17552 | 3% | 2% | 3 |
| 9 | CINET XENOBIOT | 10166 | 1% | 3% | 1 |
| 10 | PHARMACOCINET TOXICOL CLIN | 5082 | 1% | 2% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 11404 | 5% | 1% | 5 |
| 2 | EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 5455 | 5% | 0% | 5 |
| 3 | CRC CRITICAL REVIEWS IN TOXICOLOGY | 2842 | 1% | 1% | 1 |
| 4 | BIOPHARMACEUTICS & DRUG DISPOSITION | 2784 | 4% | 0% | 4 |
| 5 | JOURNAL OF PHARMACEUTICAL SCIENCES | 2424 | 10% | 0% | 9 |
| 6 | BULLETIN DU CANCER | 1991 | 5% | 0% | 5 |
| 7 | MATHEMATICAL BIOSCIENCES | 1736 | 4% | 0% | 4 |
| 8 | CYBERNETICA | 1581 | 1% | 0% | 1 |
| 9 | ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH | 1434 | 3% | 0% | 3 |
| 10 | JOURNAL OF AUTOMATION AND INFORMATION SCIENCES | 1379 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BEREZHKOVSKIY, LM , (2008) PREDICTION OF THE POSSIBILITY OF THE SECOND PEAK OF DRUG PLASMA CONCENTRATION TIME CURVE AFTER IV BOLUS ADMINISTRATION FROM THE STANDPOINT OF THE TRADITIONAL MULTI-COMPARTMENTAL LINEAR PHARMACOKINETICS.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 97. ISSUE 6. P. 2385-2393 | 12 | 75% | 2 |
| 2 | WAJIMA, T , YANO, Y , OGUMA, T , (2002) A PHARMACOKINETIC MODEL FOR ANALYSIS OF DRUG DISPOSITION PROFILES UNDERGOING ENTEROHEPATIC CIRCULATION.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 54. ISSUE 7. P. 929-934 | 13 | 72% | 12 |
| 3 | PLUSQUELLEC, Y , ARNAUD, R , SAIVIN, S , SHEPARD, TA , CARRIE, I , HERMANN, P , SOUHAIT, J , HOUIN, G , (1998) ENTEROHEPATIC RECIRCULATION OF THE NEW ANTIHYPERTENSIVE DRUG UP 269-6 IN HUMANS - A POSSIBLE MODEL TO ACCOUNT FOR MULTIPLE PLASMA PEAKS.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 48. ISSUE 2. P. 138-144 | 8 | 89% | 11 |
| 4 | MORIWAKI, T , YASUI, H , YAMAMOTO, A , (2003) A RECIRCULATORY MODEL WITH ENTEROHEPATIC CIRCULATION BY MEASURING PORTAL AND SYSTEMIC BLOOD CONCENTRATION DIFFERENCE.JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS. VOL. 30. ISSUE 2. P. 119-144 | 14 | 33% | 9 |
| 5 | PERISRIBERA, JE , TORRESMOLINA, F , GARCIACARBONELL, MC , ARISTORENA, JC , GRANERO, L , (1992) GENERAL TREATMENT OF THE ENTEROHEPATIC RECIRCULATION OF DRUGS AND ITS INFLUENCE ON THE AREA UNDER THE PLASMA-LEVEL CURVES, BIOAVAILABILITY, AND CLEARANCE.PHARMACEUTICAL RESEARCH. VOL. 9. ISSUE 10. P. 1306-1313 | 6 | 100% | 4 |
| 6 | HORKOVICS-KOVATS, S , (1999) EFFICIENCY OF ENTEROHEPATIC CIRCULATION, ITS DETERMINATION AND INFLUENCE ON DRUG BIOAVAILABILITY.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 49. ISSUE 10. P. 805-815 | 7 | 58% | 7 |
| 7 | KIM, TH , SHIN, S , LANDERSDORFER, CB , CHI, YH , PAIK, SH , MYUNG, J , YADAV, R , HORKOVICS-KOVATS, S , BULITTA, JB , SHIN, BS , (2015) POPULATION PHARMACOKINETIC MODELING OF THE ENTEROHEPATIC RECIRCULATION OF FIMASARTAN IN RATS, DOGS, AND HUMANS.AAPS JOURNAL. VOL. 17. ISSUE 5. P. 1210 -1223 | 11 | 18% | 0 |
| 8 | SEMMES, RLO , SHEN, DD , (1990) A REVERSIBLE CLEARANCE MODEL FOR THE ENTEROHEPATIC CIRCULATION OF DRUG AND CONJUGATE METABOLITE PAIR.DRUG METABOLISM AND DISPOSITION. VOL. 18. ISSUE 1. P. 80-87 | 8 | 53% | 10 |
| 9 | HOGLUND, P , OHLIN, M , (1993) EFFECT MODELING FOR DRUGS UNDERGOING ENTEROHEPATIC CIRCULATION.EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. VOL. 18. ISSUE 4. P. 333-338 | 5 | 71% | 8 |
| 10 | PLUSQUELLEC, Y , HOUIN, G , (1995) ESTIMATION OF THE EFFECTIVE AMOUNT ENTERING THE BODY FOR DRUGS SUBJECT TO ENTEROHEPATIC RECIRCULATIONS.MEDICAL ENGINEERING & PHYSICS. VOL. 17. ISSUE 3. P. 172-176 | 4 | 80% | 4 |
Classes with closest relation at Level 1 |